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Cerebral cartography can be understood in a limited, static, neuroanatomical
sense. Temporal information from electrical recordings contributes information
on regional interactions adding a functional dimension. Selective tagging and
imaging of molecules adds biochemical contributions. Cartographic detail can
also be correlated with normal or abnormal psychological or behavioural data.
Modern cerebral cartography is assimilating all these elements. Cartographers
continue to collect ever more precise data in the hope that general principles of
organizationwill emerge. However, even detailed cartographic data cannot gen-
erate knowledge without a multi-scale framework making it possible to relate
individual observations and discoveries. We propose that, in the next quarter
century, advances in cartography will result in progressively more accurate
drafts of a data-led, multi-scale model of human brain structure and function.
These blueprints will result from analysis of large volumes of neuroscientific
and clinical data, by a process of reconstruction, modelling and simulation.
This strategy will capitalize on remarkable recent developments in informatics
and computer science and on the existence of much existing, addressable data
andprior, though fragmented, knowledge. Themodelswill instantiate principles
that govern how the brain is organized at different levels and how different
spatio-temporal scales relate to each other in an organ-centred context.1. Introduction
‘An image is worth a thousandwords’.Cerebral cartography in themodern sense
means much more than anatomy (maps) or cerebral connections (routes). Rather,
the aim is to generate atlases that use anatomical frameworks to organize and
convey spatially and temporally distributed functional information about the
brain at all organizational levels, from genes to cognition, and at all the relevant
spatial and temporal scales. The ultimate brain atlas will, therefore, be an instan-
tiation of a comprehensive multi-scale understanding of the brain. In short, a
description of structural and functional principles at each scale and across all
scales (figure 1), all leading to the plethora of manifestations of whole brain
function, normal and abnormal.
Thirty years ago, most sciences were craft industries. Although high-energy
physics and astronomy had big teams and expensive instruments—particle accel-
erators, telescopes—most published research came from highly skilled scientists,
working in small laboratories, mostly in the wealthier nations. Neuroscience,
basic and clinical, followed the same pattern. Focus was an essential element
for success with grant applications. Even today, the world’s 100 000 or so neuro-
scientists work essentially on their own, each developing his or her interest, each
using established or innovative methods to dig deeper into one particular corner
of the brain. Collaborative networks and consortia are forming, often as a result of
changes in scientific funding policy, but culturally, even these new groupings
remain in the world of the traditional hypothesis-led paradigm. The results
have been astounding in scope, quality, amount and breadth. All our basic con-
cepts have come from specialized investigations by scientists working within
this traditional model. But today, that model faces serious challenges.
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Figure 1. The brain is an intrinsically multi-scale, multi-level organ operating across spatial scales ranging from nanometres ( proteins) to metres (the human body)
and temporal scales from picoseconds (atomic interactions) to years (the lifespan of a human being).
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After the pioneering work of Brodmann [1] and many others
who followed him [2,3], a key development in human brain
mapping was the introduction of maps using stereotactic coor-
dinates to identify brain regions in three-dimensional space.
This third dimension provided a vital tool for brain surgery in
humans and experimental animals. In 1967, Jean Talairach
and Pierre Tournoux published the first edition of their atlas
of the human brain, which became a basic reference for the ana-
tomical identification of brain areas localized in human
functional brain imaging studies with positron emission tom-
ography (PET) [4,5]. In 1982, George Paxinos published his
famous atlas of ‘The Rat Brain in Stereotaxic Coordinates’,
which provided an equivalent framework for the rat [6], later
going on to publish similar atlases for the rhesus monkey [7]
and the mouse [8]. These works, published in print format,
met a fundamental need. However, as time moved on, new
exigencies resulted in a series of further developments.Long before Talairach and Paxinos, Brodmann and others’
work had been criticized for its reliance on subjective classifica-
tion criteria, poor reproducibility and an inability to account for
inter-individual variation [9–11]. This criticism implied a need,
on the one hand for objective methods of parcellation and
on the other for strategies that capture anatomical variations
between individual brains.
The former need was met by the introduction of new
imaging technologies and methods for the measurement of
various brain characteristics: computerized tomography
(CT), magnetic resonance imaging (MRI: structural—sMRI;
functional—fMRI; resting state—rsMRI; and diffusion weigh-
ted imaging—DWI; various forms of tractography and
others). The availability of these new techniques led to a
massive reduction of the effort needed to produce brain atlases.
At the same time, it became imperative to create standard
schemata into which individual brains could be morphed so
that images from a variety of individuals could be averaged,
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turned human brain imaging from a radiological technique
for medical use into a quantitative science. It also led to signifi-
cant improvements in the accuracy, reliability and objectivity of
imaging data and new knowledge about human brain regions.
The result was an explosion in scientific productivity.
In parallelwith such efforts, and especially after the introduc-
tion of MRI, researchers addressed the issue of inter-individual
variability, developingprobabilistic, population-based, analytical
methods that combined computational techniques and database
technology to map individual brains onto standard anatomical
templates with spatial coordinates [12–14]. The new techniques,
based on anatomical normalization into a standard brain space
and novel statistical techniques designed to deal with multiple
non-independent comparisonsat avoxel level (e.g. as instantiated
in the Statistical ParametricMappingpackage [15]),made it poss-
ible to discover features and correlations impossible to detect in
individual brains, and to atlas the brains of specific subpopu-
lations (including subjects diagnosed with specific neurological
or psychiatric diseases). Examples of this approach include the
Montreal Neurological Institute’s reference brain, averaged
from 301 normal structural MRI scans, which became a de facto
MRI standard in the human brain imaging community and the
‘Probabilistic atlas and reference system for the humanbrain’ pro-
duced by the International Consortium for Brain Mapping
(ICBM) in 2001 [16]. In 1995, the Harvard Whole Brain Atlas
[17,18] was launched, which provided a reference three-dimen-
sional MRI/PET atlas of the human brain and which offered
the community specific databases that combined imaging and
other data relevant for collaborative analyses. Other examples
of similar approaches include the Alzheimer’s disease neuro-
imaging initiative (ADNI), an Internet-accessible database that
contains MRI, PET and other data related to ageing and
Alzheimer’s disease [19,20], the NIMH Paediatric Imaging
Study [21,22] and the Finnish Twin Registry [23].
Thanks to the availability of new imaging methods and the
rapidly increasing power and falling costs of computer memory
and database technology, many of these studies were able to
explore aspectsof thebrain thathadnotbeenmappedpreviously.
Thus, the Harvard Whole Brain Atlas provides detailed brain
maps not only for the normal brain but also for brains of patients
with cerebrovascular, neoplastic, degenerative, inflammatory
and infectious diseases. Similarly, the ICBM has deliberately
designed its atlas to quantify variance in the human brain as a
function of time (the atlas contains data from 7000 subjects
between the ages of 18 and 90). It also includes demographic, be-
havioural, clinical and genotype data so permitting correlational
andotheranalyses. TheHumanConnectomeProject, launched in
2005, uses DWI to track white matter fibres, rsMRI to document
functional connectivity, fMRI to explore effective connectivity,
sMRI for spatial localization and separate or combinedmagneto-
and electro-encephalography (MEG/EEG) for characterization
of brain dynamics. A further enhancement was the combina-
tion of imaging with extensive genetic data to characterize
brain connectivity and its variability in healthy humans.
Non-human studies have seen similar and parallel develop-
ments. Advanced database and Web technology have made it
possible to collect and organize data generated using methods
not applicable in humans, such as retrograde and anterograde
tract tracing. To cite just one example, 1996 saw the launch
of CoCo-Mac—a large electronic repository currently contain-
ing more than 40 000 experimental findings on anatomical
connections in the macaque brain [24].Gene sequencingandother -omic technologies [25–28], intro-
duced during the late 1990s and in the first decade of the twenty-
first century, togetherwith large-scale sequencingandannotation
efforts in humans, mice, chimpanzees and other species [29–33],
have made it possible to expand the range of brain atlases to
include more basic levels of brain organization. This effort, pio-
neered by the Allen Institute for Brain Sciences, has used in situ
hybridization and micro-optical tomography to produce the
first genome-wide atlas of mRNA expression in the mouse
brain (TheAllenMouseBrainAtlas) [34,35]. Thiswas soon followed
by the Allen Developing Mouse Brain Atlas, which represents the
development of mouse brain across four prenatal and three
early postnatal time points [36], and the Allen Mouse Diversity
Study, which characterizes seven strains of male and female
C57BL/6J mice in three stages of oestrus. Similar techniques
have been used to produce the Allen Human Brain Atlas [37]. In
parallelwith thiswork, theAllen Institute has combined tract tra-
cing with (EGFP)-expressing adeno-associated viral vectors and
high-throughput, serial, two-photon tomography to create the
Allen Mouse Brain Connectivity Atlas and recently, to publish the
first meso-scale representation of the mouse connectome [38].
Other organizations and research groups have exploited
new technologies to provide brain maps for other species, to
cover new levels of description and to offer maps with
higher spatial resolution than was previously possible. For
example, the National Institutes of Health-funded BrainMaps
initiative offers brain atlas datasets forMacacca mulatta, Chloro-
cebus aethiops, Felis silvestris catus, Mus musculus, Rattus
norvegicus and Tyto alba [39,40]. The NIH Blueprint Non-
Human Primate (NHP)Atlas provides a suite of gene expression
and neuroanatomical data with informatics tools for explora-
tion of the cellular and molecular architecture of macaque
brain at different stages of prenatal and postnatal development
[41]. Forschungszentrum Ju¨lich and theMontreal Neurological
Institute’s Big Brain project redefine traditional neuroanatomi-
cal maps, such as those of Brodmann and von Economo,
providing the first ultrahigh-resolution, three-dimensional
digital atlas of a human brain with a resolution of 20 mm
[42]. The BrainSpan Atlas of the Developing Human Brain, created
in a collaboration between the Allen Institute of Brain Sciences,
Yale University and other institutions, provides a spatio-tem-
poral assessment of microRNA expression throughout early
human brain development [43]. The Human Protein Atlas
Project has also produced relevant and useful data at the
proteomic scale [44,45].
This brief historical review illustrates how advances in com-
puter science, informatics, statistics and mathematics have
helped industrialize the neuroscientific process and already
impacted our understanding of the human brain. Although
theywere led by technology, these advances have entrained cul-
tural changes in the way science is done. Collaboration,
industrialization of data collection and open sharing of data
are becoming commonplace in a way that parallels the evol-
ution of other areas of science, notably in physics, astronomy,
meteorology and the material sciences. Neuroscience, however,
has beenmuch slower in taking up the advantages provided by
the informatics explosion of the last decade and a half.3. Limitations of experimental mapping
Recent years have seen enormous progress. Remarkable func-
tional data from opto-genetic techniques in animal models
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technology is continuing to advance: a recent Chinese study
has achieved Golgi staining of a whole rodent brain in
three dimensions at 1 mm resolution.
Nonetheless,muchofbrain space remains terra incognitaand
most mammalian species have yet to be investigated. Further-
more, the resolution and depth of many pioneering maps are
still limited by technology. For example, the Allen Institute’s
Human Brain Atlas represents relatively large blocks of tissue,
containing many thousands of neurons in a single volumetric
representation on a 100–300 mm grid [34]. The Human and
Mouse Connectome projects are currently restricted in their
scope to the meso-scale [38,46,47]. BigBrain provides 20 mm
resolution, a halfway house between the mesoscopic resolu-
tions of human brain maps collected in life and equivalent
microscopic studies [42].
Many have suggested that simple living organisms with
primitive nervous systems (such as Caenorhabditis elegans)
could give us vital clues. In practice, however, reconstructing
the nervous system of C. elegans has proved to be even more
difficult than reconstructing the mammalian brain: the neurons
(dendrites, axons) and synapses are too small tomake the requi-
red physiological, pharmacological and biophysical recordings!
At the opposite end of the spectrum, GenomeWide Association
Studies (GWAS) searching for genes associated with brain dis-
eases have produced relatively few significant observations
and much of the available information is hard to interpret.
Thus, a single mutation such as that of the Huntingtin gene,
which is responsible for the neurodegeneration that gives rise
to Huntington’s disease through an unknown mechanism,
can present with a variety of neurological, psychological or
behavioural symptoms.Vice versa, a syndromesuchas spino-cer-
ebellar ataxia (SCA) is currently associated with 24 different
mutations that have no obvious structural or functional relation-
ship to each other. Implicit linear hypotheses linking genes to
behaviour are for the most part false, which in retrospect is not
surprising, but was not sufficiently obvious until sometime
after the human genome was decoded.
There are many other examples in neuroscience where
cartographic knowledge has failed to provide insights into
cardinal features of behaviour. An obvious example is the
organization of the primary visual cortex. Our current under-
standing of visual cortex has evolved from a great deal of
work in North America (e.g. the school of S. Kuffler [48])
and in Europe (e.g. [49]). A cardinal example among this
work is Hubel & Wiesel’s [50] original Nobel-prize-winning
model of the primary visual cortex, based on remarkable elec-
trophysiological recordings, that has evolved over time into
today’s pinwheel model, which itself is based on imaging
of oxyhaemoglobin variation in response to specific visual
stimulation. Yet, despite these aesthetically and scientifically
pleasing results that took decades to be generated and inter-
preted, there are still many aspects of visual perception we do
not understand. For instance, many years of intensive study
with ever more exact experimental procedures and methods
have not given us an understanding of visual binding, or
even apparently simpler functions such as spatial invariance.
We do not understand how multiple visual features are pro-
cessed and then interact in the same, albeit large, cortical
space using neurons that do not reveal characteristic specifici-
ties related to differential functions, at least as described by
histological and microscopic features. We do not know
what level of biological detail is required to fully explainmany visual phenomena. How will we achieve the new
insights needed? Can we achieve them by collecting more
and more data at ever-higher resolutions? Will it be possible
in the foreseeable future to map all relevant cells and connec-
tions under all possible contexts and thus provide a
mechanistic explanation? We are explicit in answering this
rhetorical question in the negative.
A complete multi-level map of an individual human brain,
at the resolution required for mechanistic explanations—and
for detailed modelling and simulation—will have to represent
the morphologies, physiology, subcellular and molecular
architecture of some 1011 neurons and a similar number of
non-neuronal cells (oligodendrocytes, astrocytes, microglia,
etc.). More dauntingly still, it will need to represent between
1014 and 1015 synapses, each a complex sub-micron molecular
machine in its own right, as well as the modulation of neuronal,
glial and synaptic activity by neurotransmitters, peptides,
hormones and other molecules. Even if some of this complexity
is removed by grouping genes, proteins, cells and synapses
into types, the task remains formidable. It is possible today to
begin reconstructing connectivity among cells from stacks of
EM images, to identify the morphology of cells from Golgi
stains of clarified post-mortem brain tissue and to characterize
the transcriptome of single cells. However, such techniques
cannot presently be applied on the scale of the whole brain,
let alone the whole human brain. As if these considerations
were not enough, further complexity is added by temporal vari-
ations in the structure and function of individual brains (owing
to stage of development, state of oestrus, health, environmental
conditions, etc.), variations between individuals (according
to gender, experience, etc.) and variations between species,
where assumptions of homology are becoming increasingly
difficult to sustain.
Probing even deeper levels of brain organization, at the level
of the single-cell transcriptome and proteome, is evenmore dif-
ficult. Howdoes the expression of subsets of genes, estimated at
about 30% of coding genes, result in the construction of differ-
ent types of neuron? How is each of the approximately 11 000
different proteins produced addressed and sent to different
parts of this array of neuronal types? How many molecular
pathways regulate the protein–protein interactions that contrib-
ute to this molecular machinery? With approximately a billion
protein molecules in a single neuron, the number of pathways
is potentially immense. Is it possible even to imagine a complete
map of the reaction kinetics governing such interactions?
We conclude that despite the advances of the last half-
century and the extraordinary methodological developments
briefly reviewed above, information and knowledge relevant
to aspects of brain physiology and anatomy have yet to be
integrated into a comprehensive multi-scale brain model.
The reason is simple: no adequate and comprehensive reposi-
tory of such data and knowledge exists. Even if technologies
continue to improve exponentially, it seems very unlikely that
it will be possible to map more than a tiny part of brain
territory in this detail at any time in the foreseeable future.
The Blue Brain Project, a Swiss initiative to reconstruct neo-
cortical microcircuitry, is based on the most comprehensive
molecular, cellular and synaptic dataset presently available
for any brain region. The dataset is the result for thousands
of cellular level experiments, carried out in many laboratories
over a period of 30 years. Yet, together the data amount to
only a minute fraction of that needed to provide a truly com-
plete brain map. We, therefore, suggest a quite different
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the brain is organized at its various levels of description, from
genes to cognition and behaviour.
We contend that a complete understanding of the brain
cannot be achieved at any one level of brain organization, no
matter howwell it is understood at that level. What is required
is an integrated multi-level understanding. Obtaining all the
genes expressed in the brain, or in each individual neuron,
could be extremely useful for a behavioural neuroscientist,
for example, but even if such a description were possible, a
major effort would still be required to link it to behaviour.
Recording from all the neurons in the brain might also be
extremely valuable, if it were possible. But, the underlying
machinery that produces the spikeswould have to be described
before the spike patterns could be fully understood. Identifi-
cation of all the synapses connecting the brain’s constituent
neurons would provide a wealth of new insights into cerebral
network architecture and guide interpretation of activity pat-
terns. But to understand the connectome itself, it would be
necessary to relate it to molecular, electrical and pharmaco-
logical properties and principles, and to the vast repertoire of
emergent behaviours. Understanding how language is gener-
ated at the cognitive level would be an enormous step for
cognitive science, but cannot be completewithout understand-
ing the machinery that supports language, and so on. No one
level suffices to provide a comprehensive understanding of
the brain. The strategy of keeping calm and carrying on in
the same exploratory, piece-meal, scientific paradigm we are
used to will not deliver a fundamental understanding of
brain function. Even today, no onemind is capable of ingesting
and comprehending the existing neuroscientific literature, even
on a single topic such as vision. Our conclusion is that a new
approach is needed, and this is what we predict will be the
most significant development in the next 25 years of brain car-
tography. A comprehensive understanding of the brain implies
an integrated explanation of its different organizational levels
from genes to behaviour, and also an explanation of the way
the different levels cooperate with each other.4. A new paradigm
Despite the growing number of neuroscientists and exponential
growth in neuroscience publications, and despite worldwide
spending of around 7 billion Euro per annum, 1 billion in
Europe, the benefits to society from neuroscience have been
somewhat disappointing, leading politicians and industry to
question its value. Finding new diagnostic tools and new treat-
ments for brain diseases for which we have little mechanistic
or causative understanding, has become increasingly difficult.
The number of new drugs coming to market is falling and sev-
eral pharmaceutical companies have stopped investing in the
area. Neuroscience has had little authoritative to say about
reducing the risk of brain disease through nutrition, education
or social changes.
Traditional models of scientific research incentivise scien-
tists to go for ‘big discoveries’ and immediately move on,
producing results that are difficult to replicate and leaving the
data they have generated to fade away. Many clinical science
studies are underpowered. A huge number are dropped or
side lined because they do not support mainstream opinion
or yield negative results. Meanwhile, neuroscience forges
ahead without a plan for the rapidly growing volumes ofdata it produces, and without a curation process to secure its
value for the future. Medicine, locked in a symptom-based
diagnostic paradigm, struggles to move forward without a bio-
logical classification scheme for brain diseases. Plausibly, these
are some of the key factors that are slowing progress towards a
fundamental understanding of the principles of brain organiz-
ation and the way it breaks down in diseases, eroding the
impact of the considerable experimental and methodological
progress that has been made.
Neuroscience lags behind many other sciences that
have already embraced the digital era to build solid and
common foundations for collaboration in their discipline. If
we are to understand the brain across all scales and levels of
organization, we need strong foundations to work together.
Fortunately, we see signs of new paradigms and change on
the horizon.5. Big science
Big science emerges when a discipline is faced with radical,
paradigm-changing opportunities leading to transformation
of approaches and culture. Like calculus in the seventeenth cen-
tury, information and communications technology (ICT)
represents just such a transformative opportunity. Thanks to
ICT, CERN’s Large Hadron Collider (LHC) brought together
physicists from 35 countries to explore the basic building
blocks of matter—leading to the discovery of the Higgs Boson
[51]. The Human Genome Project [29,30] mapped the whole
human genome—immediately giving birth to a myriad of
other projects: the Chimpanzee Genome Project [31], the
Bonobo Genome Project [52], the Rice Genome Project [53], the
1000 Genomes Project [54,55], the 1000 Plant Genomes Project
[56] and so on. Launched in 2000, the Sloan Digital Sky Survey
(SDSS) mapped every stellar object in 35% of the sky [57,58].
NASA built the NASACentre for Climate Simulation for scien-
tists to conduct digital experiments, exploring the dynamics of
past climate change and future scenarios [59]. Today nearly
60% of articles in astrophysics are based on the analysis of exist-
ing data. In the absence of supercomputers to analyse massive
volumes of observational data and to run complex simulations
andnonlinearmodels, andwithout Internet-based long-distance
collaboration between scientists across theworld, this kind of big
science would not have been possible.
Our reflections over a half-decade suggest that it is now
possible to create a unifying framework for neuroscience
where new discoveries about brain organization can be
placed and understood. On the one hand, there is an enor-
mous number of facts in the archives of scientific articles
about normal and diseased brains, or rather, different aspects
of their anatomical, functional and biochemical organization.
On the other, the last two decades have seen an explosion
in computer science and informatics that has transformed
the lives of individuals, impacted society and is having
an effect on the cognitive function of a new generation of
scientists bought up in the informatics age.
As we have already remarked, this explosion seems to
have left basic and clinical neuroscience largely untouched
and it is not obvious why this should be so. Other sciences
have embraced the computing power of supercomputers;
the ability to curate, organize and analyse massive volumes
of data and thus to simulate and predict events and phenom-
ena. Simulation modelling is, in fact, but just one of the many
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nential growth in computing power. Advanced statistics,
notably machine and deep learning, nonlinear multi-variate
analysis and complexity mathematics are other relevant
examples. The armamentarium is large and sets the stage for
a paradigm shift from a purely hypothesis lead, reductionist
approach to neuroscience, to a data-led, hypothesis-generating
strategy, based on predictive simulation modelling. hing.org
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In 2012, these reflections were instantiated in a detailed applica-
tion for a major competitive research grant from the European
Commission’s ‘Digital Connect’ directorate. The Human Brain
Project (HBP) is a non-competitive, multi-disciplinary collabor-
ation of over 110 institutions and 181 principal investigators
who are working together on a single mission with a detailed
roadmap that describes the work needed and the milestones to
be achieved. The strategicworkplan,made possible byadvanced
computer science and informatics, focuses on threemutually rein-
forcing areas of research: ‘future neuroscience’, ‘future medicine’
and ‘future computing’. In the first stage, the mission is to build
six open infrastructures providing services for neuroinformatics,
brain simulation,medical informatics, highperformance comput-
ing, neuromorphic computing and neurobotics. The platforms,
linkedbya singleunifyingportal,will be supportedbyanexisting
network of European supercomputers, enhanced to include a
dedicated Exabyte (1018 cps) supercomputer around the turn of
the decade.
The European Commission’s HBP is turning the challenge
of mapping the human brain on its head. What we are trying
to discover are the basic rules, the biological principles, under-
lying the construction of the brainwe observe and catalogue, as
we observe them at different stages of development and in
different contexts.We conceive these principles as fundamental
rules that govern the formation of a human brain with a spec-
trum of variations that explain inter-individual variability. To
find them,we need a new ICT infrastructure capable of absorb-
ing and analysing large amounts of neuroscientific and clinical
data to derive a preliminary set of rules that govern the con-
struction of the anatomical and functional features of the
human brain. Much of the needed information resides in litera-
ture repositories and databases around the world, which
already store over 3million published papers. Initially, the digi-
tal reconstructions that we build with these rules will be
incomplete. But, their shortcomings will expose what is not
known and what is not understood and will point to the data
needed to improve them. Since the reconstructions are based
on principles suggested by available data, they can be system-
atically challenged and revised as new information becomes
available. Since the links between different levels of biological
organization are currently unknown, there is no equivalent
method for formally testing concepts. However, simulated
reconstructions can iteratively test the performance of different
sets of rules and principles, within or between levels of organ-
ization, in describing the biological reality underpinning
function. Iteration leads to adaptation and refinement of the
rules identified initially and relates them to the rest of the
architecture of the brain.
It is worth doing a mind-experiment to ask what principles
and data would be needed to predictively reconstruct, rather
than experimentally map a local microcircuit just in terms ofthe numbers, locations and types of all synapses connecting
theneurons.Weknow that the neuronal branches of neocortical
neurons pass close to very many other local neurons. This
proximity provides an opportunity for one neuron to form
connections with virtually any other without any need to
grow towards its target (a tabula rasa principle [60]). We also
know that the biological locations of synapses on neuronal
arbourizations arise largely by incidental proximity between
neighbouring neurons, suggesting that synapse location is lar-
gely prescribed by neuronal morphologies (a synapse location
principle [61]). The main challenge in predicting the local
micro-connectome is therefore to determine which of these
close appositions become synapses. When a connection is
established between two neocortical neurons, multiple func-
tional synapses are formed, so we know that synapses are
formed at several of the prescribed appositions (a multi-
synapse principle [62]). We also know that the number of
synapses correlates with the number of physical appositions
between two neurons, allowing the number of synapses
to be predicted by placing model neurons together in three-
dimensional space. Being able to predict the number and
location of synapses between any two neurons enormously
accelerates experimental mapping of all possible connections
betweenany two typesofneuron (it takes at least ayear to exper-
imentally map the connectivity between two neuron types).
Furthermore, the number of boutons an axon can form is also
limited and if each connection involves multiple boutons,
the average number of neurons it can contact is simply the
number of boutons divided by the average number of synapses
per connection. Combining these constraints with cell densi-
ties makes it possible to predict the probability that any two
neurons are synaptically connected [63].
This is just one example of interactions between some
important and significant principles (tabula rasa, synapse
location and multi-synapse) and parameters (synapses/con-
nection, bouton density, cell density, axonal arbourization
and connection probability) of local connectivity that can be
exploited to predict a complete set of all possible connections
between neurons in a local microcircuit. By analogy, related
principles will predictively reconstruct connectivity within
and between brain regions to derive an entire connectome.
We call this new paradigm of neuroscience, predictive
biology. Digital reconstruction provides a way to efficiently
apply such principles to data and to test the predictions gen-
erated. Figure 2 compares a section of a Nissl-stained whole
mouse brain with a digital reconstruction of the cell positions.
Figure 3 provides a speculative schema for a future generic
approach to predictive reconstruction of the brain, starting
at the level of single-cell gene expression data.
Iteration between a predicted reconstruction and new
experimental data is integral to refining a reconstruction and
improving predictions. Such an iterative process is not possible
without big digital science. The strategy of theHBPdepends on
the realization that a complete dataset from the brain is unat-
tainable. Indeed, there is no such thing as a complete dataset,
because, for any given brain, development, time and other con-
textual factors generate a potential infinity of ‘complete’ sets.
What we seek are generalizing principles that make it possible
to provide a reconstruction of all potential brains. The solution
is to sort out the rules that govern structural and functional
principles at each level of organization and between levels.
Working in a bottom-up, data-led manner, makes it easier to
understand how relatively complex levels of organization are
Figure 2. Predictive reconstruction of all cell positions in the whole mouse
brain. The left side of the image shows a Nissl-stained section from the Allen
Mouse Brain Atlas. The right side shows a digital reconstruction of the cell
positions (neurons and glia) obtained algorithmically by analysing the data
(C. Ero¨ et al. 2014, unpublished data).
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more precisely such rules are defined, the more constrained
the simulation problem will become and the fewer data will
be needed. The principle of obtaining more accurate predic-
tions with fewer data is analogous to a similar principle in
information theory. We postulate that the main challenge for
the next quarter century is not necessarily how to build
bigger and bigger datasets. The challenge is to reconstruct a
brain from a minimal dataset. Even small steps towards com-
plete success will produce deep insights and a parsimonious
understanding of the structural and functional organization
of the brain. No one knows how many data will be needed in
the beginning. To find out, we have to begin the process of
simulating and predicting while confronting the predictions
with biological reality at each successive stage. The HBP is
such a beginning.
It is important to state that this novel approach (data-
led simulation modelling) does not constitute a substitute for
classical hypothesis-led approaches. Rather, we think of it
as a previously untried, complementary methodology that
suggests the possibility of developing a general theory of
brain organization. By a general theory, we mean a description
of the set of rules that determine interactions between biologi-
cal levels and scales of organization, which ultimately makes it
possible to predict how biological variation at one site propa-
gates in terms of its effects to the whole brain, not only
spatially, but also in terms of functional integration. Such an
achievement would bring major benefits to all of neuroscience,
allowing new discoveries to be situated in relation to a concept
of the architecture of the brain as a whole. New discove-
ries would also serve to test the veracity of the described
underlying conceptual construct in a recurrent manner.
Other parts of the HBP focus on traditional approaches to
neuroscience. In other words, the project should be seen as
an organic extension and complement to a tradition that
comes before it. For Europe, the HBP is a unique bold step
full of scientific risk that offers major potential gains. Brain
reconstructions built on fundamental principles and fed
pragmatically with available data can help us fill vast gaps in
our knowledge and accelerate brain cartography in the next
quarter century.In the last decade, supercomputers have come of age and
now have sufficient computing power for the task at hand.
Neuroscience could become one of the biggest beneficiaries.
With a billion billion calculations per second and multi-scale
simulation technology at our disposal, it will become possible
to simulate dynamic brain processes at all levels of brain
organization, from the microscopic (molecules) to the macro-
scopic (behaviour). If the project is successful, it will provide
opportunities to design revolutionary in silico experiments,
exploring themechanisms of cognition, behaviour and disease
in ways impossible through laboratory experiments alone. It
may also become possible to build a new generation of compu-
ters using design principles based on those governing the
brain. In that event, neuromorphic computing will begin to
complement our present digital computers.7. Medical informatics
Understanding the brain implies that we understand the devel-
opmental and ageing trajectory of the brain, the manner in
which the natural and social environment shapes age-related
changes, and the way in which subtle genetic variations can
produce enormous changes in emergent behaviour. It also
means understanding similarities and differences in the way
the two genders process information, and the locations and
ways in which the design principles of the brain break down
to cause disease.
Clinical neuroscience is at a similar epistemological cross-
roads to basic neuroscience. Neurological and psychiatric
diseases are both manifestations of abnormal brain function,
yet in most countries neurology and psychiatry are separate
disciplines. Approaches to treatment are also very different.
However, both disciplines have worked and largely still
work with symptoms and syndromes, even though in cogni-
tive and behavioural disorders it is often witnesses rather
than patients who describe them to physicians. Pathological
and normal brain tissue specimens have been historically
unattainable in life because the human brain resides in a
skull. Post-mortem pathology is of questionable value in iden-
tifying disease mechanisms as it represents end-stage disease.
It is only since 1973, when the first non-invasive scanning
method (X-ray CT) was introduced, that the human brain has
begun to give up its secrets in any detail. The power of
modernmagnetic resonance scanning has been very successful
in exploring inter-regional interactions and integration at a
mesoscopic scale, for the first time providing detailed physio-
logical and anatomical descriptions of cognitive functions
[64]. Today, magnetic resonance promises an ever more soph-
isticated range of non-invasive methods for characterizing
tissue, without the use of ionizing radiation.
Genetic investigation of brain disorders has also yielded
fascinating observations. One of the most relevant for our
argument is a recent result from a large GWAS, showing
that 20 or so haplotypes are strongly associated with psychia-
tric disease in general, but that none is associated with a
specific syndromic category [65,66]. It has been shown, fur-
thermore, that in many disorders haplotypes conferring
predisposition to disease contribute little to individual risk.
Suggestions that this may be due to cumulative or interacting
associations remain to be tested and proved.
In the neurodegenerative diseases, especially those associ-
ated with ageing, diagnostic rates are poor. According to
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The HBP generalization strategy: reading gene expression patterns
Figure 3. A generic, futuristic schema for predictive reconstruction of a particular instance of a brain (a brain belonging to a specific species with a specific age and
gender, and a specific genome). The fundamental data required for future brain mapping come from analysis of gene expression patterns in single cells. These data
make it possible to consider clusters of cells with similar patterns as genetic cell types. From this starting point, many predictions become possible. By correlating
genetic cell types with morphological properties and with constraints on cellular local and global locations (position), it becomes possible to synthesize three-
dimensional models of all cell morphologies (including morphologies that have not yet been recorded) and to validate these models against known morphologies.
The same data are used to predict cellular composition (at a genetic/molecular level). This is derived by finding the distribution of genetic types that best fits
existing whole brain single gene expression maps (in terms of non-negative least squares). The predicted distribution is then validated against whole brain maps of
cellular protein expression, thus yielding a complete cellome (the set of all cell types and their respective numbers and distributions). The connectome is derived
using brain regional and inter-regional projection data, combined with known principles of synaptic connectivity at the micro-, meso- and macro-levels validated
against electron microscopic image stacks from each brain region. Correlations in single-cell transcriptomes of pairs of neurons of known genetic type, and knowledge
of the way mRNA is translated into proteins is used to predict the anatomical, physiological, molecular and plasticity properties of the synapses they form and is
validated against whole brain maps of synaptic proteins, known synaptic physiology and plasticity. Single-cell gene expression patterns, protein translation principles
and protein addressing principles are used to populate and distribute proteins (ion channels, receptors, etc.), peptides, metabolites and other biomolecules within
neurons, glia and synapses. Predictions are validated against cellular level gene and protein staining patterns. Reaction kinetics are predicted from fundamental
structure– function principles determined in dynamical simulations of molecular interactions. The results can be used to predict a complete interactome and vali-
dated against known interactions. At each stage of a reconstruction simulation, results are validated against biophysical, physiological and pharmacological data and
where appropriate, against data from cognitive and behavioural studies.
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disease in life are no better than 60–70% accurate [67,68].
Dementia as a syndrome can be caused in a number of ways.
The sub-syndromes of dementia do not breed true: a single
patient may exhibit evolving features leading to diagnosis oftwo or three syndromes over a 5–10 year period [69]. Addi-
tionally, syndromic diagnoses show little correlation with
post-mortem pathology. The mechanisms leading to the var-
ious types of dementia remain largely unknown, and it no
longer seems as if they are primarily caused by amyloid or
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until recently. In short, the road from genotype to behavioural
phenotype is not a simple one.
The clinical paradigm of functional–structural correlations
that startedwith Broca’s observations of language disturbances
caused by stroke, and that has so richly served neurologists and
psychiatrists over one and a half centuries, has now reached its
limits. As the prevalence of some of the least understood dis-
eases of the brain increases, with increasing population age,
the search for a new paradigm is vital. The social, economic
and emotional ravages that these diseases will produce are
inestimable. The brain’s large capacity to compensate for neu-
rodegeneration gives grounds for hope. A patient does not
present with Parkinson’s disease until about 60–70% of a
specific bilateral set of nigro-striatal neurons are lost [70].
This provides a window of opportunity for treatment, if we
can identify mechanisms suggesting therapeutic targets and
achieve diagnosis of pre-clinical disease.
There has been some success in the latter task, especially
through the application of machine learning to the analysis of
MRI images of the brain [71]. Recent work suggests that
identification of pre-clinical pathological states is possible in
Huntington’s disease [72] and also in Alzheimer’s disease.
In brief, informatics and analyses of large datasets offers a
possible solution to the impasse in clinical science. The ambi-
tion in this area is no smaller than in basic neuroscience,
indeed the two areas are closely related. It is clear that a
model of the brain could generate hypotheses of disease pro-
cesses and mechanisms and conversely, that abnormalities
associated with disease could serve to reconfigure a normal
brain model to assess how they propagate through the various
levels of brain organization to their phenotypic manifestations.
There is even a theoretical possibility of predicting the effects
and side effects of treatments. Congruence between disease
manifestations and predictions from a disease-configured
brain model would also constitute an excellent test of the
veracity of normal brain simulations.8. A strategy for the classification of brain
diseases
Neurological and psychiatric diseases are classified in interna-
tionally recognized, consensually derived catalogues (ICDM,
DSM-IV, DSM-V) that are based on phenotype and backed up
by ancillary investigations. Since the introduction of disease
genotyping, the emphasis on accurate phenotyping has
increased. In our view, this strategy is contentious. Firstly, phe-
notypes change with time [69]; secondly, they represent
interactions with the environment in particular developmental
contexts. Indeed, in many ways, it is surprising how useful
diagnostic categories have been, especially for diseases whose
causes and mechanisms are unknown. As soon as such mech-
anisms or causes are known, matters change. In infectious
diseases of the nervous system, the demonstration of the pres-
ence of spirochetal infection at some stage defines syphilis in
its myriad manifestations (primary, secondary, tertiary, local,
etc.). The same is true for tuberculosis (miliary, meningeal,
generalized, pulmonary primary and secondary, etc.). When
mechanisms are well understood, for example in brain infec-
tions, antibiotic resistance is attenuated by the simultaneous
use of multiple drugs that act at different sites in rotation.There exists a remarkable resource to help combat brain
diseases. This is constituted by the enormous amount of
data stored in hospital, research and pharmaceutical com-
pany databases where it remains, sometimes for a decade
or more, often for purely legal reasons. This locked up
wealth of information needs to be used rather than ignored,
not least because in socialized medical regimes, such as
those found in Europe, the taxpayer pays for the infrastruc-
ture that collects and stores it. The data should, at least in
principle, be made available for studies related to public
health as well as for individualized medicine. There are pro-
blems, not least those of privacy and informed consent, but
there are also technical solutions for dealing with them.
Technical innovation ismaking it possible to query hospital
databases by distributing queries to relevant sites. Databases
are left in situ in hospitals, where they are protected by the hos-
pitals’ own security policies and protocols. Given that original
data are never moved, there is no danger that patient records
will be corrupted. Files of different types can be accommo-
dated. Search and anonymization can be affected to the
highest industry standards, while allowing researchers to
receive aggregated results from multiple sites.
Patient records in Europe’s hospitals provide a massive
amount of data that is potentially analysable by data mining
algorithms. Advances in computer science and thewidespread
application of big data mining have clearly demonstrated that
insights can be obtained from noisy, heterogeneous and non-
standardized data. Big data analysis lies at the heart of many
of our industries and even entertainment. Since its intro-
duction, meteorological forecasts have improved enormously
in accuracy. Simulation taking all the details into account has
become industry standard practice in aircraft and spacecraft
design. Our basic idea is to use datamining to search for disease
signatures. These will define homogeneous groups of patients
characterized by a common set of quantifiable parametrized
biological and clinical variables that define the biological
make-up of theirmaladies. The types of data to be incorporated
include imaging, electrophysiology, genetics, proteins and
other blood variables commonly used in routine clinical prac-
tice, results from cerebrospinal fluid investigation and the like.
Thevarietyof normal ranges can bedealtwith bynormalization.
‘Messy’ data can be cleaned up by smoothing—a technique long
used in brain imaging to excellent effect. Absent data can be
catered for by specialized interpolations, also used effectively
in averaging brain images. However, not all issues are resolved.
For example, how should one weight the influence of a random
blood sugar value to results from genotyping with a million
single nuclear polymorphisms (SNPs)?
The underlying strategy is to populate the cerebral disease
space with homogeneous groups of patients defined by dis-
ease signatures and then to characterise them clinically and
biologically. The clinical questions will include—what is the
homogeneity of the phenotype associated with a particular
disease signature? What is the phenotypic difference between
close and distant disease signatures? Will biological character-
isation predict disease manifestations? Does the pattern of
biological characteristics suggest a disease mechanism? Are
there therapeutic implications? Given that diagnosis by dis-
ease signature, based as it is on quantifiable and definable
variables, is more accurate than diagnosis based on clinical
phenotypes, can we use this information to improve the
design of drug trials—using smaller trial populations to
achieve adequate power?
Figure 4. The figure represents subgroups of individuals of advanced age with (red) and without (blue) cognitive symptoms, obtained using an unbiased data
clustering method. The datasets contained clinical, imaging, proteomic, cerebrospinal fluid (CSF) protein and genotyping (550–1000 K SNPs) data, some of them
incomplete and from three different centres. The method divided the individuals into different subgroups in each category depending on their similarity. The
numbers in the subgroups represent the number of individuals belonging to each one. The profile of each subgroup represent specific SNPs (in black), MRI
(green) and PET (orange) patterns of focal brain atrophy or hypometabolism, proteins ( purple) and CSF proteins (sky blue). The subgroups in the normal cognition
category may represent patients with compensated pathology that goes on to cognitive decline as well as completely normal individuals of different biological ages.
The cognitive decline category also has a number of subgroups. The largest subgroup (n¼ 92) is associated with Abeta 42 in the CSF and the ApoE4 homozygotic
genotype, suggesting it may represent typical Alzheimer disease. The specificity of associations is remarkable. This is an initial, unpublished categorization based on
500 datasets provided by the 3C consortium based in Bordeaux France courtesy of Professors Dartigues and Orgogozo. Although not truly a big data analysis, which
would consist of many hundreds of thousands of individuals, the result is striking. (Figure courtesy of HBP sub-project 8, Dr F Kherif and colleagues).
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people of advanced age and found groupings that associate
expected characteristics such as genes, brain atrophy patterns
and the like (figure 4). Our study identified a number of
dementia types as well as a smaller number of normal
groups—as would be expected if some subjects were in pre-
clinical compensatory stages of pathology. Although this initial
study was based on a small dataset and does not represent a
formal proof of concept, the results are very encouraging.
Hospitals, pharmaceutical companies and research groups
are providing data for similar studies, including data fromthe placebo arms of failed trials. Having access to a range of
different types of data, from the most structured to the most
heterogeneous, will make it possible to investigate issues of
stability and sensitivity, required patient numbers and other
technical issues. There is still a need to assess data mining
algorithms and other engines with the ability to perform
complex classification on large and heterogeneous datasets.
The HBP has been running for a year, progress is rapid and
will no doubt accelerate in the same way that sequencing the
human genome accelerated. We are convinced that if our
aims are achieved, we will contribute to a cultural change,
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towards diagnoses based on biological signatures. The signatures
will together constitute amap of brain diseases thatwill relate to
the cartography that represents the biological organization of
the brain across scales. In the long run, an individual patient’s
vector of test results could be compared to such a brain disease
classification if it shows sufficient differential sensitivity and
accuracy to help diagnosis and precision medicine. hing.org
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Big science challenges past paradigms and ways of thinking—
today no one uses small telescopes for research and no one
sequences genes by hand. Few observers continue to question
the benefits of big science projects, once they are underway.
The momentum and enthusiasm created by new methods
have always translated into new jobs, new funding oppor-
tunities, new avenues for research and new industries.
Disciplines that make effective use of the power of modern
computation and data management culture—particle physics,
astronomy and genomics—are flourishing.
Without the Human Genome Project, biological and
medical research would still be in the dark ages and
the lack of clear linear relationships between genes and dis-
ease might not have been so obvious. Today, we have
hundreds of new companies dedicated to DNA sequencing,
gene-based medical diagnostics and related technologies.
Furthermore, gene sequencing has become standard practice
in a broad range of essential economical activities, including
healthcare, drug development, veterinary medicine, agricul-
ture and industrial biotechnology, and has given us the
methods we need to monitor and trace potentially pandemic
diseases like bird flu and Ebola. According to one study, the
Human Genome Project has already yielded a $US 136 return
on every dollar of public investment in the United States
alone [73]. The European HBP is beginning to have a similar
effect. Collaborative brain initiatives are emerging globally
with complementary aims. Driven by medical and economic
imperatives, many countries are placing brain research on the
top of their research agendas and providing new funding for
novel approaches. The challenge is enormous and the risks
high. However, by not trying, society risks far more. Brain
disorders already cost the European economy approximately
800 billion euros a year [74], affecting the lives of some 127
million Europeans. Can we afford not to try new solutions?
Of course, radical change often meets initial opposition. In
1990, for example, Science reported an attack on the Human
Genome Project, described as ‘mediocre science’ and ‘terrible
science policy’ [75]. Critics of ENCODE, an HGP successor
project, protested that it was ‘. . .not the work of scientists’
but of a ‘group of badly trained technicians’ [76]. There have
been similar polemics around the HBP, published by the
journal Nature [77]. For neuroscience, the idea of large, non-
competitive multi-disciplinary teams of scientists, engineers
and clinicians, working to a common vision with a mutually
agreed roadmap is a radical one. Using a common ICT infra-
structure to reconstruct a synapse, or a neuron, or a whole
brain, or to analyse patient data, or to simulate a disease or
drug effect, or to build a new computer, or design a robot,
are all major intellectual and cultural challenges. To some,
the idea of sharing ideas, knowledge, data, and tools before
publication are equally frightening. The new way of workingchallenges existing systems of credits and incentives; new
ways of recognizing contributions and promoting careers
will be needed. However, other communities such as physics
have already faced similar problems. Instead of avoiding
the issues, we can use the experience of colleagues in other
disciplines to find solutions that work for neuroscience.
Every new technology raises issues of public policy.
For instance, the HBP will analyse huge volumes of clinical
data from hospital archives, pharmacological company and
research databases and other sources, searching for biological
signatures of disease. Acquiring these data has already cost tril-
lions of euro of public money, yet the majority remain unused.
Exploiting them could bring added value for public health,
while simultaneously yielding enormous rewards in terms of
better diagnosis, treatment and precision medicine. Technical
solutions from modern ICT pave the way for policies that
open up clinical data for analysis, while simultaneously
providing effective protection for patient privacy.
Maintaining large data resources and new ICT infrastruc-
tures will also require new funding models. Which models
should be chosen? Maximizing the economic and social
benefits of a new model of discovery will require new incen-
tives for sharing data and tools as well as new models
making it easier for international teams to share intellectual
property. In all these areas, scientists, citizens and patients
have the right and duty to challenge decisions by scientists
and policy-makers. One of our most important challenges is
to find ways for everyone to participate in the debate.
As happens with all disruptive technologies, big digital
science is rapidly becoming part of our daily lives. We believe
that the application of big digital science to neuroscience
will provide radically new opportunities to develop a
modern cartography of the brain, with a firm grounding in
well-established discoveries and methods, allowing us to
understand the basic principles of brain architecture and
leading us towards theories of the brain, that translate into
benefits, not just for medicine but for society.10. Conclusion
The brief we received from the editor of this special issue of
Philosophical Transactions was to look 25 years into the
future of cerebral cartography: to imagine what cerebral car-
tography will be like then. Already today, cartography has
evolved from a way of identifying brain regions and localizing
them for use by neurosurgeons, to an anatomical framework
on which information about local tissue properties and func-
tions can be distributed to obtain a view of the brain’s
structural and functional architecture. Informatics and compu-
tational power are speeding up this evolution—crossing
species boundaries, accounting for inter- and intra-individual
variability, providing representations of different levels of
brain organization across different spatial and temporal scales.
The resulting atlases will become repositories of information
associated with particular locations in the brain. Now, we
have to use this information to generate a blueprint for brain
organizationacross all scales, to create a theoryofbrain function,
which helps to identify new information needed to progress-
ively and iteratively refine the atlases, and to revise our
current classifications of brain diseases, allowingmore effective
diagnosis, prognosis and treatment. As instigators of the HBP,
together with our colleague Prof. Karlheinz Meier, a leader in
rstb.royalso
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some of these ideas into practice. We are also content that we
seem to have an answer to the philosophical question ‘how
can the brain understand itself?’ The answer—‘By exploring
itself with the addition of massive computing power and data cmanagement capacity, as provided by modern computer
science and informatics’.
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